Calpain 10 is an atypical calpain ubiquitously exist in all human tissues. It exhibits eight protein isoforms designated as "a-h" which play a vital role in glucose homeostasis but actual mechanism of action is yet to be ascertained. We have predicted the partial roles of Isoform a, c and g previously. They were envisaged to act partially as mu and m-calpain cysteine proteases. Here we predict the function of minor isoforms b, d, e, f and h. We have applied NCBI Blast and Conserved domain tool for nucleotide and protein alignments. Blast query indicated 87%, 84%, 87%, 94% and 34% identity of isoform b, d, e, f and h with canonical sequence of calpain 10 a isoform. Conserved domain analyses of protein sequences revealed significant structural similarities of their N-terminal domain I and II with catalytic domain of cysteine protease superfamily PC1 (e-value:CAPN10b, d, e = 2.41e-76, CAPN10f = 1.07e-43 and CAPN10h = 1.13e-17). Isoform b, d and e have one consecutive domain similar with C2 like subdomain III (e-value=2.92-32, 1.03e-35, 1.88e-14 respectively) and was classified in CAPN10 group of Palb subfamily. Isoform f and h were lacking this domain and had shorter sequences. Although structural similarities are not guaranteed for similar actions but domain homology predicted the existence of similar functions as of calpain I and II.
INTRODUCTION
The calpain 10 is an atypical cysteine protease. It plays an active role in the development of type 2 diabetes predicted after complete genome scan analyses [1] . Calpain 10 as a member of a superfamily of proteases, is thought to be calcium activated, nonlysosomal, neutral, cysteine protease which partially proteolysis its substrates. The partial proteolysis results in the modulation of its substrate functions by either activation or inhibition of the molecules. It is ubiquitously found in all tissues of human body. It is found in cytosol as well as in mitochondria [2] . The overexpression of calpain 10 proteins results in mitochondrial dysfunction [3, 4] , as they cleave the electron transport chain proteins and a decrease in fatty acid oxidation for production of ATP, which increases the intracellular fatty acyl CoA and diacylglycerol (DAG) levels in mitochondria and disrupts insulin signaling. These molecules activate protein kinase C, which is also a substrate of calpain10. Increased amount of protein kinase C in turn activates a serine kinase cascade leading to increased serine phosphorylation of insulin receptor substrate 1 (IRS-1). This serine phosphorylation at critical sites inhibits the IRS-1 tyrosine phosphorylation by insulin receptor and results in inhibition of insulin-stimulated *Address correspondence to this author at the Department of Biological & Biomedical Sciences, The Aga Khan University, Stadium Road, Karachi, Pakistan; Tel: 34930051, Ext.4326; E-mail: bushra.chaudhry@aku.edu glucose transport and causing insulin resistance in skeletal muscle and liver [5] . Splicing of calpain 10 mRNA results in the formation of eight different isoforms (a-h). We hypothesized that the isoforms which we are analyzing for individual functional prediction may behave in a similar mode as described above. These isoforms are originating from calpain 10 largest isoform. The Genetic variation in calpain 10 gene has been studied in several ethnic populations of the world and resulted in low expression of calpain 10 proteins. The mechanism by which calpain 10 involved with disease(s) is not yet exactly known. It was previously reported that calpain 10 protein expression is induced by physical training [6] . A band of 60kDa of calpain 10 protein (represents isoform b, c and d) observed after Immunoblotting in skeletal muscles of endurance trained control subjects and not in diabetic patients. These results indicated that physical activity rather than insulin resistance may influence the regulation of calpain 10 protein levels in human skeletal muscle [6] . Bioinformatics tools are actively used to foretell the functions of molecules for their in vivo behavior and mechanisms of action on the basis of their nucleotide and amino acid sequences, three dimensional structures and conserve domain analyses. Three major and ubiquitously found isoforms (a, c and g) were previously been analyzed by our group and were found homologous to cysteine protease superfamily but 3D-structure analysis revealed that they have their own unique 3-dimentional structures.
The aim of our study was to predict the mechanism of action of calpain 10 minor isoforms b, d, e, f and h and their involvement in the development of type 2 diabetes and other diseases using bioinformatics approaches mainly on the basis of their domain homology, providing some information about the function.
MATERIALS AND METHODS
Protein sequences of Calpain 10 isoforms b, d, e and h were obtained from UniProt KB (www.uniprot. org). These minor isoforms were examined for nucleotide and protein sequence similarity using multiple alignment tools on NCBI blast Align tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
The blast nucleotide algorithm (blastn) first breaks the query sequence into the short subsequences (words) and then identifies the exact matches. These hits were used to generate final alignment. In contrast, standard protein-protein blast (blastp) identified a query sequence as well as other similar sequences in protein databases. Calpain 10 isoform a was used as canonical sequence to determine the alignment analysis of calpain 10 b, d, e and h. Domain homology of calpain 10 minor isoforms with other Homo sapiens proteins were analyzed by Conserved Domain tool (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb). It used templates from SMART, COG, Protein Clusters and Pfam databases for alignments [7] [8] [9] . It was used to predict the domain homology of a query protein with other proteins on the basis of structural similarity and used to predict the function of that particular domain.
RESULTS
Results of this study showed that minor isoforms b, d and e have similar structural (Figure 1 ) and domain homology with isoforms a, whereas isoform f and h are different. The nucleotides and amino acids sequences were showed the blast query coverage of 87%, 84%, 87%, 94% and 34% identity with canonical sequence of calpain 10 a for isoform b, d, e, f and h respectively Table 1 ) revealed significant domain similarities of their Nterminal domain I and II with catalytic domain of cysteine protease superfamily PC1 and PC2 with an evalue of CAPN10b = 2.41e-76, CAPN10d = 2.47e-76, CAPN10e = 6.45e-75, CAPN10f = 1.07e-43 and CAPN10h = 1.13e-17. Calpain 10 isoform b, d and e have one consecutive domain (Figure 3 ) which was found to be as similar with C2 like subdomain III of mulike calpain (e-value=2.92-32, 1.03e-35, 1.88e-14) and was classified in CAPN10 group of Palb subfamily. Isoforms f and h were found to be shorter proteins and only have catalytic cysteine protease domain ( Figure  4 ).
DISCUSSION
Calpain 10 on the basis of its structure homology studies belongs to the cysteine protease super family. Generally, calpains function in the cytoskeletal remodeling process, cell differentiation, apoptosis and signal transduction as reported previously [10] . Calpains being proteases, serve as bio-modulators for other peptides. Our results predicted the possible activity and mechanism of action of studied protein isoforms of calpain 10 which have originated from post translational processing. Structural homology indicated that Isoform b, d, e, f and h have sequence similarity with canonical sequence of isoform a with shorter sequences. They do share common domains which may be involved in similar type of function as the largest isoform a ensures in the development of type 2 diabetes. Further all these isoforms have membrane bound sequences and actually are from mitochondrial origin as described for some members of superfamily [11] . They may play a critical role in mitochondrial dysfunction if there expression will decrease. two N-terminal domains as similar to the cysteine protease superfamily domain PC1 and PC2. This domain may perform three functions 1) accepts calcium ions and induces activation of their own or other proteins, 2) it may involve in mediating interaction with phospholipids and their translocation to cytoplasmic/nuclear membranes, 3) it maintain the stability of cysteine proteases. These functions are predicted on the bases of observed similarity. This domain is followed by C2 like domain subdomain III (CD Accession: cd00214). There are two C2 like domain subdomain III in isoform b and d and one in isoform e. This observation predicts that isoform b and d acts like an electrostatic switch which to form a functional catalytic center which will be stronger in case of isform b and d as compared to isoform e. The presence of cysteine protease superfamily proteolytic domain in calpain 10 isoforms may play a vital role in calcium induced activation of their own or other proteins directly or indirectly by mediating interaction with phospholipids and their translocation to cytoplasmic/nuclear membranes. According to the previous reports, domain I and domain II exhibit protease activity because it contains catalytic active site at locations Cys105, His262 and Asn286 [12] . Our results are lacking the application of tool to find the active site residues in isoforms. The function of subdomain III of mu-like calpain is known to have capability to bind with calcium and phospholipid as described previously [13] . We interpret that similarity with this domain in isoforms b, d and e might form electrostatic interaction with domain II to facilitate calpain interaction as shown in model (Figure 5 ) with phospholipids and cell membranes (cytoplasmic/ nuclear) to release insulin which is similar as described previously for calpain 2 [12, 14] . Further we agree with the previous reports indicating that this interaction may assists to mediate the maintenance of the catalytic core in an inactive form, membrane binding and also for stabilization of the active enzyme [13, [15] [16] [17] . Isoform f and h have two domains similar to the cysteine protease superfamily; therefore it might lack the capability to bind with phospholipids and cell membrane and only possesses week protease activity, which may be random.
Conserved domain analysis of isoforms showed two types of proteolytic domains. Isoform b, d and e have
It is predicted from the observation that calpain 10 minor isoforms b, d and e isoforms may have a role of protein modulator as cysteine protease because of their domain I & II similarity with the protease domain of cysteine protease superfamily having domain III homology with subdomain III of mu-like calpain (calpain 2). Since these have found b, d and e isoforms contain membrane binding sequences and are originally as mitochondrial proteins there up and down regulation will be highly involved in the causation of insulin secretion, insulin resistance and hence diabetes type 2. Protein kinase C is regulated by calpain 10 isoforms being a substrate, decreased expression levels of calpains isoforms b, d and e will increase the amount of protein kinase C directly which in turn will activate the serine kinase cascade leading to increased serine phosphorylation of insulin receptor substrate 1 (IRS-1). This serine phosphorylation at critical sites will inhibits the IRS-1 tyrosine phosphorylation by insulin receptor and will results in inhibition of insulin-stimulated glucose transport and causing insulin resistance.
Further, secretion of insulin from pancreatic beta cells is a complex process involving the integration and interaction of multiple external and internal stimuli. It involves nutrients, hormones, neurotransmitters, and drugs all activate or inhibit insulin release. The calpain isoforms may also play a role because of the presence of domains, involved in binding with phospholipids make them candidates for the secretion of insulin from pancreatic beta cells.
In case of isoforms b, d and e the increased intracellular Ca 2+ influx after elevation in the ATP/ADP ratio and cell membrane depolarization triggers the exocytosis of insulin. This may be a result of dissociation of domain III from domain II b to form a catalytic center to bind with membrane phospholipid and translocation of insulin vesicles from cytosol to membrane. In case if amount of calpain proteins are scanty (down regulated) there will be low level of calpain to bind with calcium and to release the catalytic centers for attachment to phospholipids and hence for release of insulin. Calpain 10 isoform f and h might have papain like activity as they only got cysteine protease superfamily domain, making them week proteases to act randomly to chop off proteins under certain physiological conditions. We include them in mitochondrial sub population as reported for some other proteins [18, 19] .
